HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circulating resistin levels and risk of multiple myeloma in three prospective cohorts.

AbstractBACKGROUND:
Resistin is a polypeptide hormone secreted by adipose tissue. A prior hospital-based case-control study reported serum resistin levels to be inversely associated with risk of multiple myeloma (MM). To date, this association has not been investigated prospectively.
METHODS:
We measured resistin concentrations for pre-diagnosis peripheral blood samples from 178 MM cases and 358 individually matched controls from three cohorts participating in the MM cohort consortium.
RESULTS:
In overall analyses, higher resistin levels were weakly associated with reduced MM risk. For men, we observed a statistically significant inverse association between resistin levels and MM (odds ratio, 0.44; 95% confidence interval (CI) 0.24-0.83 and 0.54; 95% CI 0.29-0.99, for the third and fourth quartiles, respectively, vs the lowest quartile; Ptrend=0.03). No association was observed for women.
CONCLUSIONS:
This study provides the first prospective evidence that low circulating resistin levels may be associated with an increased risk of MM, particularly for men.
AuthorsLoredana Santo, Lauren R Teras, Graham G Giles, Stephanie J Weinstein, Demetrius Albanes, Ye Wang, Ruth M Pfeiffer, Qing Lan, Nathaniel Rothman, Brenda M Birmann, Graham A Colditz, Michael N Pollak, Mark P Purdue, Jonathan N Hofmann
JournalBritish journal of cancer (Br J Cancer) Vol. 117 Issue 8 Pg. 1241-1245 (Oct 10 2017) ISSN: 1532-1827 [Electronic] England
PMID28829767 (Publication Type: Journal Article)
Chemical References
  • ADIPOQ protein, human
  • Adiponectin
  • RETN protein, human
  • Resistin
Topics
  • Adiponectin (blood)
  • Aged
  • Australia (epidemiology)
  • Case-Control Studies
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Multiple Myeloma (blood, epidemiology)
  • Multivariate Analysis
  • Odds Ratio
  • Prospective Studies
  • Resistin (blood)
  • Risk
  • Sex Factors
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: